Altered microRNA expression profile in maternal and fetal liver of HBV transgenic mouse model

Reference

• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function.Cell 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Pfeffer S. Identification of virally encoded microRNAs.Meth Enzymol 2007;427:51–63.
   PubMedGoogle Scholar
• Voinnet O. Induction and suppression of RNA silencing: insights from viral infections.Nat Rev Genet 2005;6:206–220.
   PubMed Web of Science ®Google Scholar
• Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi.Science 2002;297:1833–1837.
   PubMed Web of Science ®Google Scholar
• Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs.Science 2005;309:1519–1524.
   PubMed Web of Science ®Google Scholar
• Peng X, Li Y, Walters KA, Rosenzweig ER, Lederer SL, Aicher LD, Proll S, Katze MG. Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers.BMC Genomics 2009;10:373.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao JJ, Wang CM, Li MY, Han P, Wang L, Cheng YQ, et al. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line.Chin Med J 2009;122:10–14.
   PubMedGoogle Scholar
• Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, Velayudham A, Szabo G. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice.Alcohol Clin Exp Res 2009;33:1704–1710.
   PubMed Web of Science ®Google Scholar
• Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, Zhang LJ, Keshavarzian A. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease.Alcohol Clin Exp Res 2008;32:355–364.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ. Circulating microRNAs, potential biomarkers for drug-induced liver injury.Proc Natl Acad Sci USA 2009;106:4402–4407.
   PubMed Web of Science ®Google Scholar
• Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.Hepatology 1990;12:671–675.
   PubMed Web of Science ®Google Scholar
• Braillon A, Lerat A, Lansac J, Dubois G. [In France, prevention of vertical transmission of hepatitis B virus infection must be improved. A questionnaire survey in Picardie]. J Gynecol Obstet Biol Reprod (Paris) 2010;39:478–483.
   PubMedGoogle Scholar
• Koedijk FD, op de Coul EL, Boot HJ, van de Laar MJ. [Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions]. Ned Tijdschr Geneeskd 2007;151:2389–2394.
   PubMedGoogle Scholar
• Ye MJ, Zhang CW, Pei XF, Zhou R, Liu J, Wen YQ, Wang DX, Liu WF. [Prevention of vertical transmission of HBV infection to the fetus from the mother by HBIG and hepatitis B vaccine]. Hua Xi Yi Ke Da Xue Xue Bao 1986;17:212–215.
   PubMedGoogle Scholar
• Ely A, Naidoo T, Mufamadi S, Crowther C, Arbuthnot P. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.Mol Ther 2008;16:1105–1112.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Ely A, Bloom K, Weinberg MS, Arbuthnot P. Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles.Biochem Biophys Res Commun 2009;389:484–489.
   PubMedGoogle Scholar
• McCaffrey AP. RNA interference inhibitors of hepatitis B virus.Ann N Y Acad Sci 2009;1175:15–23.
   PubMedGoogle Scholar
• Gao YF, Yu L, Wei W, Li JB, Luo QL, Shen JL. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.World J Gastroenterol 2008;14:4684–4689.
   PubMedGoogle Scholar
• Chen XM. MicroRNA signatures in liver diseases.World J Gastroenterol 2009;15:1665–1672.
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in transgenic mice.J Virol 1995;69:6158–6169.
   PubMed Web of Science ®Google Scholar
• Brechtbuehl K, Whalley SA, Dusheiko GM, Saunders NA. A rapid real-time quantitative polymerase chain reaction for hepatitis B virus.J Virol Methods 2001;93:105–113.
   PubMedGoogle Scholar
• Lok AS. Hepatitis B infection: pathogenesis and management.J Hepatol 2000;32:89–97.
   PubMed Web of Science ®Google Scholar
• Katami K, Taguchi F, Nakayama M, Goto N, Fujiwara K. Vertical transmission of mouse hepatitis virus infection in mice.Jpn J Exp Med 1978;48:481–490.
   PubMedGoogle Scholar
• Tsuge M, Hiraga N, Takaishi H, Noguchi C, Oga H, Imamura M, Takahashi S, et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.Hepatology 2005;42:1046–1054.
   PubMed Web of Science ®Google Scholar
• Bagis H, Arat S, Mercan HO, Aktoprakligil D, Caner M, Turanli ET, Baysal K, et al. Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation.J Exp Zoolog Part A Comp Exp Biol 2006;305:420–427.
   PubMedGoogle Scholar
• Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases.World J Gastroenterol 2009;15:5633–5640.
   PubMed Web of Science ®Google Scholar
• Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.Hepatology 2009;49:1098–1112.
   PubMed Web of Science ®Google Scholar
• Pan J, Clayton M, Feitelson MA. Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin.J Gen Virol 2004;85:275–282.
   PubMedGoogle Scholar
• Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, Yang JR, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.Carcinogenesis 2008;29:2126–2131.
   PubMed Web of Science ®Google Scholar
• Su F, Theodosis CN, Schneider RJ. Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein.J Virol 2001;75:215–225.
   PubMedGoogle Scholar
• Zhang SY, Gu HX, Li D, Yang SF, Zhong ZH, Li XK, Jin X. Association of human leukocyte antigen polymorphism with hepatitis B virus infection and genotypes.Jpn J Infect Dis 2006;59:353–357.
   PubMed Web of Science ®Google Scholar
• Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. miR-122, a paradigm for the role of microRNAs in the liver.J Hepatol 2008;48:648–656.
   PubMed Web of Science ®Google Scholar
• Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y, Aoki T, et al. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.Pathol Int 2010;60:351–357.
   PubMed Web of Science ®Google Scholar
• Uziel T, Karginov FV, Xie S, Parker JS, Wang YD, Gajjar A, He L, et al. The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma.Proc Natl Acad Sci USA 2009;106:2812–2817.
   PubMed Web of Science ®Google Scholar
• Chang J, Provost P, Taylor JM. Resistance of human hepatitis delta virus RNAs to dicer activity.J Virol 2003;77:11910–11917.
   PubMed Web of Science ®Google Scholar
• Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.RNA Biol 2004;1:106–113.
   PubMedGoogle Scholar